|
For Participants
The report of the Workshop should be presented
to the health authorities.
The clinical use of blood should be advocated.
The formation of a Hospital Transfusion
Committee should be suggested, and medical audit system introduced.
CME programmes must
be conducted for their colleagues and the knowledge gained in this workshop
disseminated.
Standard operating procedures (SOP) for good
clinical practice should be prepared and used in their hospitals.
The proper use of blood in their hospitals
should be ensured which includes avoiding use of fresh whole blood, using
components wherever available, avoiding over and under usage of blood, and
evaluating the patient rationally to assess the need for blood transfusion.
For Member Countries
A national blood policy and an action plan
should be developed which includes clinical use of blood.
Blood transfusion services should be
strengthened and component separation facilities provided.
An effective regulatory mechanism based on
standards for blood transfusion services should be developed.
Guidelines for clinical use of blood should be
prepared and a system of haemovigilance introduced.
Transfusion Medicine should be introduced as a
subject in the medical curricula.
For WHO
WHO should continue to provide technical
assistance to countries in strengthening their blood transfusion services and
advocacy for clinical use of blood.
Additional training programmes
on the clinical use of blood should be organized to develop a large core
group of national trainers in this field.
Training materials on the clinical use of
blood should be prepared to be utilized by participants for undertaking
training programmes in their countries/
institutions.
A follow-up exercise should be undertaken with
all the participants of the workshop through a structured questionnaire.
|